Health TRACON Pharmaceuticals Announces up to $30M Non-Recourse Globe News Wire Dec 28, 2022 SAN DIEGO, Dec. 27, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel…